Incidence, severity, and mortality of post-ERCP pancreatitis: A systematic review by using randomized, controlled trials

Gastrointestinal Endoscopy

Volumn 81, Issue 1, 2015, Pages 143-149.e9

  Kochar, Bharati ^a   Akshintala, Venkata S ^a   Afghani, Elham ^a   Joseph Elmunzer, B ^b   Kim, Katherine J ^a   Lennon, Anne Marie ^a   Khashab, Mouen A ^a   Kalloo, Anthony N ^a   Singh, Vikesh K ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COCHRANE LIBRARY; DISEASE SEVERITY; EMBASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HIGH RISK PATIENT; HUMAN; INCIDENCE; MEDLINE; MORTALITY; NORTH AMERICAN; OUTCOME ASSESSMENT; PANCREATIC DUCT STENT; PANCREATITIS; POST ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VATER PAPILLA STENOSIS; ADVERSE EFFECTS; SEVERITY OF ILLNESS INDEX; STENT;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; INCIDENCE; PANCREATITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; STENTS;

EID: 84923004695     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2014.06.045     Document Type: Article

References (131)

1. A.F. Peery, E.S. Dellon, and J. Lund Burden of gastrointestinal disease in the United States: 2012 update Gastroenterology 143 2012 1179 1187
2. B.J. Elmunzer, A.K. Waljee, and G.H. Elta A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis Gut 57 2008 1262 1267
3. M. Freeman, and N. Guda Prevention of post ERCP pancreatitis: a comprehensive review Gastrointest Endosc 59 2004 845 864
4. M. Freeman, C. Overby, and D. Qi Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success Gastrointest Endosc 59 2004 8 14
5. A. Andriulli, S. Loperfido, and G. Napolitano Incidence rates of post ERCP complications: a systematic survey of prospective studies Am J Gastroenterol 102 2007 1781 1788
6. W. Zhou, Y. Li, and Q. Zhang Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases Pancreatology 11 2011 399 405
7. C.L. Cheng, S. Sherman, and J.L. Watkins Risk factors for post-ERCP pancreatitis: a prospective multicenter study Am J Gastroenterol 101 2006 139 147
8. P.A. Testoni, A. Mariani, and A. Giussani Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study Am J Gastroenterol 105 2010 1753 1761
9. P. Wang, Z.S. Li, and F. Liu Risk factors for ERCP-related complications: a prospective multicenter study Am J Gastroenterol 104 2009 31 40
10. J.S. Mallery, T.H. Baron, and J.A. Dominitz Complications of ERCP Gastrointest Endosc 57 2003 633 638
11. Lefebvre C, Manheimer E, Glanville J. Searching for studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011. Available at: http://www.cochrane.org/training/cochrane-handbook. Accessed January 18, 2012.
12. Agency for Healthcare Research and Quality. Methods reference guide for effectiveness and comparative effectiveness reviews, version 1.0 (draft posted October 2007). Rockville, MD. Available at: http://effectivehealthcare.ahrq.gov/repFiles/2007-10DraftMethodsGuide.pdf. Accessed August 3, 2013.
13. D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
14. Higgins JPT, Altman DG, Sterne JAC, editors. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011. Available at: http://www.cochrane.org/training/cochrane-handbook. Accessed January 18, 2012.
15. P.B. Cotton, G. Lehman, and J.A. Vennes Endoscopic sphincterotomy complications and their management: an attempt at consensus Gastrointest Endosc 37 1991 383 391
16. B.J. Elmunzer, J.M. Scheiman, and G.A. Lehman A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis N Engl J Med 366 2012 1414 1422
17. M.L. Freeman, J.A. DiSario, and D.B. Nelson Risk factors for post-ERCP pancreatitis: a prospective, multicenter study Gastrointest Endosc 54 2001 425 434
18. M. Freeman Understanding risk factors and avoiding complications with endoscopic retrograde cholangiopancreatography Curr Gastroenterol Rep 5 2003 145 153
19. E. Masci, G. Toti, and A. Mariani Complications of diagnostic and therapeutic ERCP: a prospective multicenter study Am J Gastroenterol 96 2001 417 423
20. R.J. Farrell, N. Mahmud, and N. Noonan Diagnostic and therapeutic ERCP: a single large centre's experience Ir J Med Sci 170 2001 176 180
21. T. Rabenstein, and E.G. Hahn Post ERCP pancreatitis: is the endoscopists experience the major factor? J Pancreas 3 2002 177 187
22. S. Varadarajulu, M.L. Kilgore, and C.M. Wilcox Relationship among hospital ERCP volume, length of stay, and technical outcomes Gastrointest Endosc 64 2006 338 347
23. S.T. Cooper, and A. Slivka Incidence, risk factors and prevention of post ERCP pancreatitis Gastroenterol Clin North Am 36 2007 259 276
24. S. Loperfido, G. Angelini, and G. Benedetti Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study Gastrointest Endosc 48 1998 1 10
25. Cotton PB, Romagnuolo J, Freeman M, et al. Evaluating predictors and interventions in sphincter of Oddi dysfunction. In: clinicaltrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-2013. Available at: http://clinicaltrials.gov/ct2/show/record/NCT00688662 NLM Identifier: NCT00688662. Accessed August 24, 2013.
26. A. Abbasinazari, M.A.H. Alizadeh, and K. Moshiri Does allopurinol prevent post endoscopic retrograde cholangio-pancreatography pancreatitis? A randomized double blind trial Acta Med Iran 49 2011 579 583
27. C.G. Alveyn, D.A. Robertson, and R. Wright Prevention of sepsis following endoscopic retrograde cholangiopancreatography J Hosp Infect 19 Suppl C 1991 65 70
28. A. Andriulli, L. Solmi, and S. Loperfido Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate Clin Gastroenterol Hepatol 2 2004 713 718
29. A. Andriulli, R. Clemente, and L. Solmi Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial Gastrointest Endosc 56 2002 488 495
30. R. Arcidiacono, P. Gambitta, and A. Rossi The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy Endoscopy 26 1994 715 718
31. D. Arvanitidis, J. Hatzipanayiotis, and G. Koutsounopoulos The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP Hepatogastroenterology 45 1998 248 252
32. G. Baldazzi, C. Conti, and E.G. Spotti Prevention of post-ERCP acute pancreatitis with octreotide [in Italian] G Chir 15 1994 359 362
33. O. Barkay, E. Niv, and E. Santo Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial Surg Endosc 22 2008 1971 1976
34. M. Beauchant, P. Ingrand, and J.M. Favriel Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo controlled multicenter trial Endoscopy 40 2008 631 636
35. T.S. Bexelius, J. Bloomberg, and Y.X. Lu Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopancreatography: a randomized clinical trial World J Gastrointest Endosc 4 2012 506 512
36. V. Bhatia, V. Ahuja, and S.K. Acharya A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis J Clin Gastroenterol 45 2011 170 176
37. K.F. Binmoeller, A.G. Harris, and R. Dumas Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut 33 1992 1129 1133
38. G. Borsch, M. Bergbauer, and W. Nebel [Effect of somatostatin on amylase level and pancreatitis rate following ERCP] Med Welt 35 1984 109 112
39. R. Brust, A.B. Thomson, and R.H. Wensel Pancreatic injury following ERCP. Failure of prophylactic benefit of Trasylol Gastrointest Endosc 24 1977 77 79
40. A. Budzynska, T. Marek, and A. Nowak A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis Endoscopy 33 2001 766 772
41. G. Cavallini, A. Tittobello, and L. Frulloni Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy-Italian Group N Engl J Med 335 1996 919 923
42. H.H. Chan, K.H. Lai, and C.K. Lin Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography J Chin Med Assoc 71 2008 605 609
43. X.T. Chen, Z. Feng, and Y.F. Shen Clinical observation on ulinastatin for the prevention of post-ERCP pancreatitis Shandong Med J 45 2005 44 45
44. Y.K. Cheon, K.B. Cho, and J.L. Watkins Efficacy of diclofenac in the prevention of post ERCP pancreatitis in predominantly high-risk patients: a randomized double blind prospective trial Gastrointest Endosc 66 2007 1126 1132
45. C.W. Choi, D.H. Kang, and G.H. Kim Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis Gastrointest Endosc 69 2009 e11 e18
46. G.D. De Palma, and C. Catanzano Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study Am J Gastroenterol 94 1999 982 985
47. J. Deviere, O. Le Moine, and J.L. Van Laethem Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography Gastroenterology 120 2001 498 505
48. G.Q. Ding, M.F. Qin, and F.S. Zou Oral magnesium prevents the development of pancreatitis and hyperamylasemia in patients after ERCP World Chin J Digest 20 2012 1570 1573
49. Z. Dobronte, E. Toldy, and L. Mark [Effects of rectal indomethacin in the prevention of post ERCP pancreatitis] Orvosi Hetilap 153 2012 990 996
50. J.A. Dumot, D.L. Conwell, and G. Zuccaro Jr. A randomized, double blind study of interleukin-10 for the prevention of ERCP-induced pancreatitis Am J Gastroenterol 96 2001 2098 2102
51. J.A. Dumot, D.L. Conwell, and J.B. O'Connor Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial Am J Gastroenterol 93 1998 61 65
52. M. Duvnjak, V. Supanc, and V. Simicevic A randomized double-blind trial of the efficacy of octreotide acetate administration in the prevention of abdominal pain following therapeutic endoscopic retrograde cholangiopancreatography Acta Clin Croat 40 2001 9 13
53. B.J. Elmunzer, J.M. Scheiman, and G.A. Lehman A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis N Engl J Med 366 2012 1414 1422
54. A. Fazel, A. Quadri, and M.F. Catalano Does a pancreatic duct stent prevent post ERCP pancreatitis? A prospective randomized study Gastrointest Endosc 57 2003 291 294
55. P. Gong, Z. Wang, and P.J. Tai Prevention and treatment for post ERCP pancreatitis J Hepatobiliary Surg 12 2004 101 103
56. M. Guelrud, S. Mendoza, and L. Viera Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis Gastrointest Endosc 37 1991 44 47
57. H.B. Guo, H.R. Li, and S.X. Li Somatostatin versus endoscopic nasal biliary drainage in the prevention of post-ERCP pancreatitis and hyperamylasemia World Chin J Digest 20 2012 2427 2431
58. X.L. Hua, Q.J. Bo, and G.L. Gen Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla J Gastroenterol Hepatol 26 2011 1139 1144
59. P.S. Jowell, M.S. Branch, and S.H. Fein Intravenous synthetic secretin reduces the incidence of pancreatitis induced by endoscopic retrograde cholangiopancreatography Pancreas 40 2011 533 539
60. A.J. Kaffes, M.J. Bourke, and S. Ding A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis Gastrointest Endosc 64 2006 351 357
61. D. Kapetanos, D. Christodoulou, and O. Chatzizisi Randomized study of the effect of pentoxifylline or octreotide on serum levels of TNF-alpha and IL-6 after endoscopic retrograde cholangiopancreatography Eur J Gastroenterol Hepatol 21 2009 529 533
62. D. Kapetanos, G. Kokozidis, and D. Christodoulou A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis Gastrointest Endosc 66 2007 513 518
63. P. Katsinelos, K. Fasoulas, and G. Paroutoglou Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double blind, placebo-controlled trial Endoscopy 44 2012 53 59
64. P. Katsinelos, J. Kountouras, and J. Chatzis High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial Gastrointest Endosc 61 2005 407 415
65. P. Katsinelos, J. Kountouras, and G. Paroutoglou Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis Gastrointest Endosc 62 2005 105 111
66. K. Kwanngern, P. Tiyapattanaputi, and M. Wanitpukdeedecha Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study J Med Assoc Thai 88 Suppl 4 2005 S42 S45
67. Y.H. Kwon, J.Y. Kim, and S.J. Lee Could nafamostat or gabexate prevent the post endoscopic retrograde cholangiopancreatography pancreatitis? Korean J Gastroenterol 59 2012 232 238
68. A. Lavy, A. Karban, and A. Suissa Natural beta-carotene for the prevention of post-ERCP pancreatitis Pancreas 29 2004 e45 50
69. K.T. Lee, D.H. Lee, and B.M. Yoo The prophylactic effect of somatostatin on post-therapeutic endoscopic cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial Pancreas 37 2008 445 448
70. T.H. Lee, J.H. Moon, and H.J. Choi Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study Gastrointest Endosc 76 2012 578 585
71. C.G. Liu, D.Y. Leng, and H. Liu [Effect of qingyi decoction in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia] Zhongguo Zhong Xi Yi Jie He Za Zhi 29 2009 607 610
72. G. Manes, S. Ardizzone, and G. Lombardi Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized controlled, multicenter study Gastrointest Endosc 65 2007 982 987
73. A. Mariani [Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography] Giorn Ital End Dig 27 2004 39 41
74. S. Manolakopoulos, A. Avgerinos, and J. Vlachogiannakos Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial Gastrointest Endosc 55 2002 470 475
75. M. Matsushita, H. Takakuwa, and N. Shimeno Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis J Gastroenterol 44 2009 71 75
76. M. Matsushita, H. Takakuwa, and N. Shimeno Prophylactic injection of hypertonic saline epinephrine oral to the papilla for prevention of postsphincterotomy bleeding J Chin Gastroenterol 44 2010 e167 e170
77. J. Milewski, G. Rydzewska, and M. Degowska N-acetylcysteine does not prevent post endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis World J Gastroenterol 12 2006 3751 3755
78. A. Montano Loza, C.J. Garcia, and O.A. Gonzalez Prevention of hyperamilasemia and pancreatitis after endoscopic retrograde cholangiopancreatography with rectal administration of indomethacin [in Spanish] Rev Gastroenterol Mex 71 2006 262 268
79. A. Montano Loza, X. Rodriguez Lomeli, and J.E. Garcia Correa Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes [in Spanish] Rev Esp Enferm Dig 99 2007 330 336
80. M. Moreto, M. Zaballa, and I. Casado Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial Gastrointest Endosc 57 2003 1 7
81. P. Mosler, S. Sherman, and J. Marks Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis Gastrointest Endosc 62 2005 245 250
82. B. Murray, R. Carter, and C. Imrie Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography Gastroenterology 124 2003 1786 1791
83. V. Nikolopoulou, K. Thomopoulos, and K. Vagenas The effect of octreotide on TNF-alpha production by peripheral blood monocytes in patients after ERCP Surg Res Comm 17 1995 269 275
84. C. Nojgaard, M. Hornum, and M. Elkjaer Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double blind, placebo-controlled multicenter trial Gastrointest Endosc 69 2009 e31 e37
85. H.S. Odes, B.N. Novis, and G.O. Barbezat Effect of calcitonin on the serum amylase levels after endoscopic retrograde cholangiopancreatography Digestion 16 1977 180 184
86. H.C. Oh, Y.K. Cheon, and Y.D. Cho Use of udenafil is not associated with a reduction in post-ERCP pancreatitis: results of a randomized, placebo-controlled, multicenter trial Gastrointest Endosc 74 2011 556 562
87. T. Otsuka, S. Kawazoe, and S. Nakashita Low-dose rectal diclofenac for prevention of post endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial J Gastroenterol 47 2012 912 917
88. K.T. Park, D.H. Kang, and C.W. Choi Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas 40 2011 1215 1219
89. B. Persson, P. Slezak, and S. Efendic Can somatostatin prevent injection pancreatitis after ERCP? Hepatogastroenterology 39 1992 259 261
90. R.T. Poon, C. Yeung, and C.L. Liu Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial Gut 52 2003 1768 1773
91. R.T. Poon, C. Yeung, and C.M. Lo Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial Gastrointest Endosc 49 1999 593 598
92. F. Prat, J. Amaris, and B. Ducot Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study Gastrointest Endosc 56 2002 202 208
93. T. Rabenstein, B. Fischer, and V. Wiessner Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis Gastrointest Endosc 59 2004 606 613
94. S. Raty, J. Sand, and M. Pulkkinen Post-ERCP pancreatitis: reduction by routine antibiotics J Gastrointest Surg 5 2001 339 345
95. J. Romagnuolo, R. Hilsden, and G.S. Sandha Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial Clin Gastroenterol Hepatol 6 2008 465 471
96. A. Russo, C. Virgilio, and G. Aprile Effect of octreotide on pancreatic reactions following ERCP [in Italian] Giorn Ital End Dig 15 1992 139 145
97. A. Saari, E. Kivilaakso, and T. Schroder The influence of somatostatin on pancreatic irritation after pancreatography. An experimental and clinical study Surg Res Comm 2 1988 271 278
98. J. Sand, and I. Nordback Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography Digestion 54 1993 105 111
99. J.J. Schwartz, R.J. Lew, and N.A. Ahmad The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis Gastrointest Endosc 59 2004 179 184
100. A. Senol, U. Saritas, and H. Demirkan Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitis World J Gastroenterol 15 2009 3999 4004
101. T.U. Shah, R. Liddle, and M.S. Branch Pilot study of aprepitant for prevention of post ERCP pancreatitis in high risk patients: a phase II randomized, double blind placebo controlled trial JOP 13 2012 514 518
102. Z.S. Shen-Li, X. Pan, and W.J. Zhang Effect of octreotide administration in the prophylaxis of post ERCP pancreatitis and hyperamylasemia: a multicenter, placebo controlled, randomized clinical trial Am J Gastroenterol 102 2007 46 51
103. S. Sherman, W.M. Alazmi, and G.A. Lehman Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis Gastrointest Endosc 69 2009 462 472
104. S. Sherman, U. Blaut, and J.L. Watkins Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study Gastrointest Endosc 58 2003 23 29
105. S. Sherman, C.L. Cheng, and G. Costamagna Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk Pancreas 38 2009 267 274
106. A. Smithline, W. Silverman, and D. Rogers Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients Gastrointest Endosc 39 1993 652 657
107. A. Sofuni, H. Maguchi, and T. Itoi Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent Clin Gastroenterol Hepatol 5 2007 1339 1346
108. A. Sofuni, H. Maguchi, and T. Mukai Endoscopic pancreatic duct stents reduce the incidence of post endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients Clin Gastroenterol Hepatol 9 2011 851 858
109. A.L. Song, L. Yang, and Z.M. Kou Preventive effects of ulinastatin on post ERCP hyperamylasemia and acute pancreatitis J Lanzhou Univ 31 2005 24 25
110. R. Sotoudehmanesh, M. Khatibian, and S. Kolahdoozan Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP Am J Gastroenterol 102 2007 978 983
111. J.M. Sternlieb, C.A. Aronchick, and J.N. Retig A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis Am J Gastroenterol 87 1992 1561 1566
112. S. Sudhindran, E. Bromwich, and P.R. Edwards Prospective randomized double-blind placebo controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis Br J Surg 88 2001 1178 1182
113. A. Talwar, C. Dare, and J. Pain Does topical GTN on the sphincter of Oddi facilitate ERCP? A double-blind randomized control trial Surg Endosc 19 2005 902 904
114. W.F. Tao, Q.W. Wang, and Q.L. Li Preventive effect of 5-fluorouracil on post-ERCP pancreatitis [in Chinese] Zhong Nan Da Xue Xue Bao Yi Xue Ban 29 2004 201 203
115. P.R. Tarnasky, Y.Y. Palesch, and J.T. Cunningham Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction Gastroenterology 115 1998 1518 1524
116. P.A. Testoni, F. Bagnolo, and A. Andriulli Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial Aliment Pharmacol Ther 15 2001 965 972
117. P.A. Testoni, M. Cicardi, and L. Bergamaschini Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy Gastrointest Endosc 42 1995 301 305
118. P.A. Testoni, E. Masci, and F. Bagnolo Endoscopic papilla-sphincterotomy: prevention of pancreatic reaction by somatostatin Ital J Gastroenterol 20 1988 70 73
119. K.C. Thomopoulos, N.A. Pagoni, and K.A. Vagenas Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post- ERCP pancreatitis Gastrointest Endosc 64 2006 726 731
120. H.M. Torres, X.R. Lomeli, and C.D. Cobian Oral allopurinol to prevent hyperamylasemia and acute pancreatitis after endoscopic retrograde cholangiopancreatography World J Gastroenterol 15 2009 1600 1606
121. T. Tsujino, Y. Komatsu, and H. Isayama Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial Clin Gastroenterol Hepatol 3 2005 376 383
122. Z. Tulassay, and J. Papp The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography Gastrointest Endosc 37 1991 48 50
123. K.A. Ung, L. Rydberg, and S. Modin A preventive effect of unfractionated heparin on post-ERCP pancreatitis is suggested by positive effects on laboratory biomarkers Hepatogastroenterology 58 2011 168 173
124. T. Wehrmann, T. Schmitt, and N. Stergiou Topical application of nitrates onto the papilla of Vater: manometric and clinical results Endoscopy 33 2001 323 328
125. C.Y. Wei, J. Yang, and P. Zhao Clinical study of prophylactic effect of proton pump inhibitor combined with somatostatin and gabexate on post-ERCP pancreatitis and hyperamylasemia Chin J Gastroenterol 14 2009 414 417
126. D.J. Westerloo, E.A. Rauws, and D. Hommes Pre-ERCP infusion of semapimod, a mitogen-activated protein kinase inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence Gastrointest Endosc 68 2008 246 254
127. S. Wollschlager, K. Patzold, and T. Bulang Effect of preventive selenium administration on development of ERCP-induced acute pancreatitis [in German] Med Klin (Munich) 94 Suppl 3 1999 81 83
128. G.S. Xiong, S.M. Wu, and X.W. Zhang Clinical trial of gabexate in the prophylaxis of post endoscopic retrograde cholangiopancreatography pancreatitis Braz J Med Biol Res 39 2006 85 90
129. K.S. Yoo, K.R. Huh, and Y.J. Kim Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial Pancreas 40 2011 181 186
130. J.W. Yoo, J.K. Ryu, and S.H. Lee Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo controlled trial Pancreas 37 2008 366 370
131. U. Yusuf, O. Necati, and K. Selim Role of somatostatin in the prevention of pancreatic reactions in patients undergoing endoscopic retrograde cholangio-pancreatography (ERCP) Turk Gastro 10 1999 48 51